ACTRN12616000305426已完成未知
In patients with non-alcoholic steatohepatitis, is high intensity interval training safe, feasible and effective for improving fitness and insulin sensitivity.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 70 Years(—)
- 性别
- All
入选标准
- •Men and women who are not currently meeting physical activity guidelines (<150 minutes of moderate or <75 min of vigorous exercise per week), aged 18-70 years, with biopsy-proven NASH.
排除标准
- •Unstable angina; Recent (4 weeks) myocardial infarction; Coronary Artery Disease; Uncompensated heart failure; New York Heart Association (NYHA) Functional Classification II-IV; Severe valvular illness; Pulmonary disease; Uncontrolled hypertension (systolic blood pressure > 200 mmHg and/or diastolic blood pressure >110 mmHg); Renal failure (Chronic Kidney Disease stages III-V); Orthopedic/neurological limitations; Cardiomyopathy; Planned operations during the research period; Physical impairment limiting the ability to exercise; Drug or alcohol abuse; Planning to or participation in another study; Not willing to sign the consent from; Females pregnant or expecting to be pregnant during the study period; Lactating females; Contraindication to exercise testing/training; Medication affecting insulin sensitivity and/or evidence of cirrhosis; Any other reason which would limit their ability to participate in this study.
研究者
相似试验
已完成
不适用
Analysis of nonalcoholic steatohepatitis and the risk of cardiovascular event in terms of lipid metabolism abnormalityonalcoholic fatty liver diseaseJPRN-UMIN000009614Yokohama City University Graduate School of Medicine100
招募中
不适用
on-invasive diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease using markers and imaging techniquesfatty liver with inflammation10019654non-alcoholic steatohepatitisNL-OMON47211Medisch Universitair Ziekenhuis Maastricht110
招募中
不适用
A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing AtarNASHNCT06193629Shupei Li150
招募中
不适用
Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced FibrosisNonalcoholic SteatohepatitisNCT05720663Virginia Commonwealth University240
尚未招募
不适用
on-alcoholic Fatty Liver Disease Dietary TrialACTRN12612000841875Catherine Properzi66
